While name brands like Adderall and Vyvanse may have been recently removed from the FDA Drug Shortage Database, it's unclear ...

Patients with amblyopia had a statistically significant improvement in their visual acuity after binocular rehabilitation ...

The authors emphasize the value of subgroup analyses for tracking patterns in spinal muscular atrophy (SMA), as opposed to ...

Accompanying these findings is a call for refined treatment strategies that have potential to better outcomes among patients ...

Tyler Sandahl, PharmD, of Mayo Clinic, and Michael Byrne, DO, of Tennessee Oncology, discuss practical advice for bringing ...

Bhattacharya's nomination, alongside Robert F. Kennedy Jr. and Mehmet Oz, indicates potential shifts in vaccine policy under ...

An exploration of emerging strategies to overcome resistance to HER2-directed therapies based on ongoing research advancements.

A review of recent clinical trial results for emerging HER2-directed therapies, including SOHO-01, inetetamab/pyrotinib, and ...

Antifibrotic treatment rates for IPF differ significantly between referral hospitals and general hospitals or clinics, with ...

Real-world outcomes for HER2-positive NSCLC differ from clinical trials due to diverse patient populations and treatment ...

On this episode of Managed Care Cast, we speak with the author of a study published in the November 2024 issue of The ...

If made official, the proposed rule would give Part D and Medicaid beneficiaries expanded coverage to antiobesity drugs ...